NME
Notis-McConarty Edward Portfolio holdings
AUM
$205M
This Quarter Return
-0.92%
1 Year Return
+14.8%
3 Year Return
+72.99%
5 Year Return
+119.96%
10 Year Return
+295.3%
AUM
$167M
AUM Growth
+$167M
(-4.1%)
Cap. Flow
-$1.69M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
34.66%
Holding
89
New
–
Increased
19
Reduced
42
Closed
3
Top Buys
| 1 |
Fiserv
FI
|
$1.92M |
| 2 |
Danaher
DHR
|
$99.4K |
| 3 |
Unilever
UL
|
$93.9K |
| 4 |
Analog Devices
ADI
|
$82K |
| 5 |
CELG
Celgene Corp
CELG
|
$69.4K |
Top Sells
| 1 |
Microsoft
MSFT
|
$428K |
| 2 |
NVIDIA
NVDA
|
$354K |
| 3 |
US Bancorp
USB
|
$345K |
| 4 |
Mastercard
MA
|
$336K |
| 5 |
Wells Fargo
WFC
|
$315K |
Sector Composition
| 1 | Technology | 24.71% |
| 2 | Healthcare | 24.58% |
| 3 | Industrials | 15.56% |
| 4 | Financials | 8.01% |
| 5 | Consumer Staples | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$821B
| $2.06M | 1.24% |
18,772
-555
| -3% | -$61K |
|
27
PepsiCo
PEP
$207B
| $1.9M | 1.14% |
17,441
-100
| -0.6% | -$10.9K |
|
28
Oracle
ORCL
$630B
| $1.81M | 1.08% |
39,537
-675
| -2% | -$30.9K |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $1.72M | 1.03% |
19,278
+778
| +4% | +$69.4K |
|
|
XLNX
30
DELISTED
Xilinx Inc
XLNX
| $1.71M | 1.02% |
23,645
+245
| +1% | +$17.7K |
|
31
Illumina
ILMN
$15.3B
| $1.49M | 0.89% |
6,283
-47
| -0.7% | -$11.1K |
|
|
32
NVIDIA
NVDA
$4.12T
| $1.45M | 0.87% |
6,275
-1,530
| -20% | -$354K |
|
33
Emerson Electric
EMR
$73.7B
| $1.41M | 0.85% |
20,650
| – | – |
|
34
Honeywell
HON
$138B
| $1.4M | 0.84% |
9,649
-1,200
| -11% | -$173K |
|
35
Lowe's Companies
LOW
$145B
| $1.39M | 0.83% |
15,800
-200
| -1% | -$17.5K |
|
36
Bristol-Myers Squibb
BMY
$96.5B
| $1.36M | 0.82% |
21,511
-200
| -0.9% | -$12.7K |
|
37
Union Pacific
UNP
$131B
| $1.35M | 0.81% |
10,050
-200
| -2% | -$26.9K |
|
38
Cisco
CSCO
$270B
| $1.34M | 0.8% |
31,290
-140
| -0.4% | -$6K |
|
39
Xylem
XYL
$34.1B
| $1.33M | 0.8% |
17,295
-650
| -4% | -$50K |
|
40
Chevron
CVX
$326B
| $1.25M | 0.75% |
10,930
-450
| -4% | -$51.3K |
|
41
Merck
MRK
$212B
| $1.21M | 0.73% |
22,230
-600
| -3% | -$32.7K |
|
42
Stryker
SYK
$149B
| $1.21M | 0.72% |
7,525
-220
| -3% | -$35.4K |
|
43
DuPont de Nemours
DD
$31.6B
| $1.16M | 0.69% |
18,126
-16
| -0.1% | -$1.02K |
|
44
Qualcomm
QCOM
$169B
| $1.16M | 0.69% |
20,845
| – | – |
|
45
Gilead Sciences
GILD
$140B
| $1.15M | 0.69% |
15,272
+75
| +0.5% | +$5.66K |
|
46
Colgate-Palmolive
CL
$68.1B
| $1.08M | 0.65% |
15,035
-460
| -3% | -$33K |
|
47
Fortive
FTV
$15.9B
| $1.07M | 0.64% |
13,792
| – | – |
|
48
Diageo
DEO
$61.3B
| $1.07M | 0.64% |
7,865
-100
| -1% | -$13.5K |
|
49
GE Aerospace
GE
$291B
| $966K | 0.58% |
71,685
-13,070
| -15% | -$176K |
|
50
Accenture
ACN
$159B
| $894K | 0.54% |
5,825
-51
| -0.9% | -$7.83K |
|